Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Recruiting 6Not yet recruiting 3Completed 2Active not recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Leukemia, Myeloid, Acute 1Hematopoietic and Lymphatic System Neoplasm 1Breast Neoplasms 1

Interventions

Carboplatin 126Cisplatin 125Drug Therapy 104Bevacizumab 98Oxaliplatin 97Capecitabine 96Radiotherapy 94Gemcitabine 87Paclitaxel 85tislelizumab 84Cyclophosphamide 83Specimen Handling 80pembrolizumab 76toripalimab 67Magnetic Resonance Spectroscopy 63Injections 62Fluorouracil 62sintilimab 57anlotinib 53Surgical Procedures, Operative 50130-nm albumin-bound paclitaxel 50Docetaxel 49fludarabine 46Pemetrexed 45Standard of Care 43venetoclax 42Leucovorin 42Biopsy 42Irinotecan 41lenvatinib 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × axatilimab × Clear all
NCT07015853 2026-04-20

ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation

Cedars-Sinai Medical Center

Phase 2 Not yet recruiting
34 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07349771 2026-04-16

Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial

Mayo Clinic

Phase 2 Not yet recruiting
72 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT07511062 2026-04-06

Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML

Northside Hospital, Inc.

Phase 1 Not yet recruiting
32 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡